Please login to the form below

Not currently logged in
Email:
Password:

The Access Partnership hires Mike Mallinson

He joins with more than 30 years’ experience gained both on agency and client-side

London-based The Access Partnership, part of the The Research Partnership, has appointed Mike Mallinson as president of the market access consultancy firm.

Mallinson has more than 30 years' experience, gained both on agency and client-side. Most recently he served as UK MD for market access, and pricing and reimbursement specialists, Double Helix Consulting, while prior to this he established a payer, pricing, reimbursement and market access practice within GfK's healthcare division.

In his new role, Mallison will be supported by Rob White, global director of market access and Dr Shrinivas Rao Mukku, global director of pricing and reimbursement.

“I am delighted to be taking on this challenging new position,” said Mallinson.

“Our aim is for The Access Partnership to become the preferred commercial partner for delivering market access solutions, by gaining a reputation for delivering the best payer and key stakeholder insights and outstanding strategic consulting services.

“We recognise the access challenges facing our clients, particularly across the Tier I and Tier II emerging markets - having an Asia Pacific presence will mean we are well placed to meet our clients' needs in this region.”

2nd November 2012

From: Marketing, Healthcare

Share

Tags

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

Has the pandemic opened up a future of accelerated diagnosis and better care for rare disease patients?
The challenge with rare disease is in the name – it's rare, so awareness is limited and diagnosis hindered. Could a more virtual existence change this? A Medical Affairs viewpoint...
The other side of … blood cancer
To stay motivated for the fight, some patients need to feel like active players in the treatment journey, not passengers to every decision....
COVID clinical trial
COVID-19 – a catalyst for technology adoption in clinical trials
As the COVID-19 crisis disrupts clinical trials around the globe, it is also proving to be a catalyst that may transform its approach to trials for good...

Infographics